An international program for multiple-substance withdrawal should assess the combined clinical situation and assign clear medical responsibility. A long list of substances on a website does not establish that a service can manage their combined effects, existing prescriptions, physical illness, and psychiatric needs in one setting.
Begin with an assessment where the person is located and give the receiving team a complete history. Then compare the program’s actual capabilities with the recommendation. A clinically appropriate plan may involve one service, several coordinated services, or local care before any international transfer.
Explain the whole pattern, including uncertainty
List alcohol, prescribed medicines, nonprescribed drugs, supplements, and recent changes. Describe the pattern of use and the time sequence as accurately as possible, including substances used to stay awake, sleep, manage anxiety, or relieve discomfort.
If a product’s contents or strength are uncertain, say so. Do not turn an informal name or an estimate into a precise pharmaceutical description. The assessing team needs to know which information is reliable and which remains uncertain.
Our polysubstance treatment guide covers the broader clinical discussion. The purpose of the history is to help the clinician understand the combined situation, not to require a perfect account before help can begin.
Do not assume one substance cancels another
The CDC’s polysubstance guidance explains that combining stimulants and depressants does not balance their effects and can produce unpredictable results. Alcohol can also increase risks when combined with other substances.
This matters when someone interprets feeling calmer or more alert as proof that the situation has improved. Report the substances and symptoms to a clinician rather than using the apparent effect of one drug to dismiss another.
If there is severe confusion, a seizure, breathing difficulty, collapse, chest pain, or immediate danger from suicidal intent, seek urgent local medical help. An overseas program’s future availability does not address a current emergency.
Distinguish the tasks inside the assessment
The clinicians may need to assess intoxication, withdrawal concerns, existing medication treatment, physical health, and psychiatric symptoms. These tasks can involve different expertise, but the resulting recommendations need to form one coherent plan.
Ask which professional integrates the findings. If several prescribers are involved, determine how they communicate and who resolves conflicting instructions. The patient should not have to decide which clinician’s medication advice takes priority.
The WHO and UNODC treatment standards describe coordinated treatment across needs and settings. They provide a useful framework for questions, without proving that an individual program delivers every component.
Ask substance-specific questions without building a home protocol
A combined assessment should recognize that different substances raise different concerns. The ASAM alcohol withdrawal guideline, for example, addresses medical setting and withdrawal management, while the stimulant guideline also emphasizes psychiatric and ongoing treatment needs.
Use these distinctions to ask what the service can assess and manage. Do not try to merge separate online instructions into a personal withdrawal plan or decide which substance to stop first without clinical advice.
Our detox abroad assessment guide explains the initial decision. The receiving team should identify the combined needs and the limits of its setting before acceptance is treated as final.
Protect clinically indicated medicines
A person may take medication for opioid use disorder, anxiety, epilepsy, pain, sleep, or another condition while also using nonprescribed substances. Each medicine needs review in context. Its presence does not automatically mean it should be stopped.
The MHRA’s current dependence and withdrawal guidance distinguishes physical dependence from addiction and emphasizes individualized decisions when more than one relevant medicine is involved.
Ask the receiving clinician how existing treatments will be continued or reviewed. A broad medication-free policy should not silently displace an appropriate prescribing plan. If the service cannot support a required treatment, that is a capability question to resolve before travel.
Compare the actual clinical coverage
Request a description of the medical and psychiatric team assigned to the case. Ask who is present, who is available remotely, and who can make decisions during a change in condition.
A practical comparison can separate these functions:
| Clinical function | What the proposal should identify |
|---|---|
| Combined assessment | The clinician integrating substance and health history |
| Prescribing | Responsibility for each current and proposed medicine |
| Physical monitoring | Staff, review process, and escalation |
| Psychiatric care | Assessment capability and response to deterioration |
| External services | Named referral route and transfer responsibility |
A program does not need to deliver every service under one roof to be useful. It does need to explain how necessary care is obtained without leaving responsibility unclear.
Verify the overnight setting
Ask what happens after scheduled consultations finish. Who notices and assesses a change in symptoms? How is a doctor contacted? What happens if the patient requires a service that is unavailable within the residence?
Our hospital versus residential guide examines these questions. Terms such as staffed around the clock or medical support can describe very different arrangements. Request the actual roles rather than infer them from the wording.
If hospital care is external, establish the transfer process and how relevant records accompany the patient. A transport driver, a companion, and a medical escort have different responsibilities and should not be treated as interchangeable.
Include co-occurring mental health needs
Describe depression, anxiety, unusual beliefs, hallucinations, trauma-related symptoms, and previous psychiatric treatment. Tell the team whether these occurred before substance use, during periods without use, or after changes in medication.
The National Institute of Mental Health supports coordinated attention to substance use and co-occurring mental health disorders. Ask which symptoms need immediate attention and which questions will be reassessed over time.
Our integrated dual diagnosis comparison explores shared care. A program should not require every psychiatric concern to wait until an arbitrary detox milestone if the current clinical assessment indicates a need for earlier treatment.
Make admission criteria visible
Ask which findings would make the proposed program unsuitable or require another service first. A clear scope statement is more useful than an assurance that a private team can handle everything.
Clarify whether acceptance is based on a clinical review or remains conditional on assessment after arrival. Identify changes that must be reported before departure, such as a new medicine, further substance use, or worsening symptoms.
If a service proposes local stabilization before residential care, request the actual sequence. Who assesses, who accepts the next transfer, and what documents or clinical findings are needed? A sequence should be workable before its dates are treated as fixed.
Check the itinerary against the medication plan
An international journey may involve several countries and different rules for prescribed controlled medicines. Use the INCB’s country information to identify relevant authorities and verify the current requirements for the actual route.
The CDC’s substance use travel chapter highlights restrictions affecting medicines used in treatment. A home prescription is not universal permission to carry or obtain a product abroad.
Our medication management guide covers the transfer of prescribing information. Confirm both the border documentation and the receiving service’s ability to provide the intended treatment; solving only one leaves the plan incomplete.
Translate the important records accurately
Provide current prescriptions, relevant discharge summaries, allergies, major diagnoses, and contact details for existing clinicians. Ask the receiving team which documents need translation and whether a clinician-to-clinician discussion is required.
A short summary should distinguish established information from uncertain history. It should also identify recent changes rather than present an old medication list as current. Keep an accessible copy while using the agreed process for clinical transfer.
If English is the shared language, confirm that urgent care and overnight instructions are also understandable in English. An English-language admissions website does not establish that every part of the clinical pathway has the same communication capability.
Evaluate two kinds of proposal carefully
A program may advertise many substances but rely on a narrow residential model with limited medical cover. Another may describe a smaller direct scope while arranging specific hospital and specialist services when needed. Neither should be judged by the number of labels alone.
Ask each to explain how it would implement the assessed plan, including its limits. A coordinated external service may be suitable if responsibility and access are confirmed; an impressive service list may be less useful if important details remain vague.
This comparison concerns capability, not prestige. The patient’s clinicians should determine whether the proposed arrangement can support the combined needs in practice.
Resolve conflicting instructions before the transition
If one document says a medicine continues and another says it stops, contact the responsible clinicians for clarification. Do not choose between instructions based on which document looks newer or which coordinator sounds more confident.
Ask for the corrected plan to be shared with the patient, prescriber, dispensing service, and receiving team as appropriate. Explain any language or memory difficulties that make written instructions particularly important.
A mixed-substance history can involve several records and several services. The practical test is whether the patient can identify one current plan and the professional responsible for it. If that remains unclear, make the uncertainty explicit before the person is transferred to another setting.
Arrange a single continuing-care handoff
Before the initial episode ends, obtain one current medication plan and an understandable clinical summary. Confirm which service will take over, when the first appointment occurs, and who handles questions in the interval.
Our detox and rehab handover guide examines transfers between phases. If several organizations are involved, each should know its responsibility rather than assume another team has arranged follow-up.
The useful outcome is a coherent care pathway that remains understandable to the patient and receiving clinicians. Every substance and medicine belongs in the assessment, but the result should be one coordinated plan rather than a collection of conflicting instructions.